Healthcare Most Volatile: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), OXiGENE Inc (NASDAQ:OXGN), Intrexon (NYSE:XON), Enzon Pharmaceuticals (NASDAQ:ENZN)

Idenix Pharmaceuticals (NASDAQ:IDIX) , which had its hepatitis C drugs put on clinical hold because it had a similar structure to Bristol-Myers Squibb’s BMS-986094, which had serious cardiac side effects. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock performance was -6.45% in last session and finished the day at $7.11. Traded volume was 3,306,727 million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Most Volatile: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), OXiGENE Inc (NASDAQ:OXGN), Intrexon (NYSE:XON), Enzon Pharmaceuticals (NASDAQ:ENZN)

FB Nasdaq FB Facebook

Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

On March 5, 2014, Opexa Therapeutics, Inc. (NASDAQ:OPXA) entered into a First Amendment to Sales Agreement (the “First Amendment”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P.) (the “New Sales Manager”) and Brinson Patrick Securities Corporation (the “Original Sales Manager”). Pursuant to the First Amendment, the Sales Agreement dated September 6, 2012 by and between the Company and … Continue reading Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

Biotech Volatile Stocks: Intrexon Corp (NYSE:XON), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Sangamo Biosciences, Inc. (NASDAQ:SGMO), Osiris Therapeutics, Inc. (NASDAQ:OSIR)

Intrexon Corp (NYSE:XON) COO Krish Krishnan purchased 20,900 shares of Intrexon Corp (NYSE:XON) stock in a transaction that occurred on Friday, May 9th. The stock was purchased at an average price of $14.21 per share, for a total transaction of $296,989.00. Following the purchase, the chief operating officer now directly owns 20,900 shares in the company, valued at approximately $296,989. Intrexon Corp (NYSE:XON) stock performance … Continue reading Biotech Volatile Stocks: Intrexon Corp (NYSE:XON), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Sangamo Biosciences, Inc. (NASDAQ:SGMO), Osiris Therapeutics, Inc. (NASDAQ:OSIR)

Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

MannKind Corp. (NASDAQ: MNKD) was raised to Neutral from Underweight by Piper Jaffray. MannKind Corporation (NASDAQ:MNKD) stock performance was 6.53% in last session and finished the day at $7.01. Traded volume was 16.68million shares in the last session and the average volume of the stock remained 10.11million shares. The beta of the stock remained 1.40. MannKind Corporation (NASDAQ:MNKD) insider ownership is 0.30%. Celldex Therapeutics, Inc. … Continue reading Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

FireEye, Inc. (NASDAQ: FEYE) filed a registration with the U.S. SEC to sell, from time to time, up to 13,282,316 shares of its Common Stock on behalf of Selling Shareholders. FireEye Inc (NASDAQ:FEYE) stock performance was 5.05% in last session and finished the day at $50.57. Traded volume was 6.04million shares in the last session and the average volume of the stock remained 3.61million shares. … Continue reading Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)